(MedPage Today) -- No excess in target lesion failure but signal for late thrombosis
via Meta-analysis: More Very Late Thrombosis With Absorbing Stent? (CME/CE)
by
Tuesday, January 3, 2017
NeuroBreak: Spinraza's $750K Price Tag; Bial Skipped PD Data
(MedPage Today) -- News and commentary from the world of neurology and neuroscience
via NeuroBreak: Spinraza's $750K Price Tag; Bial Skipped PD Data
by
via NeuroBreak: Spinraza's $750K Price Tag; Bial Skipped PD Data
by
Pearls From: Michael Mack, MD
(MedPage Today) -- Five reasons for caution on TAVR for intermediate-risk patients
via Pearls From: Michael Mack, MD
by
via Pearls From: Michael Mack, MD
by
ACP: Metformin as First Oral Tx for T2D (CME/CE)
(MedPage Today) -- New guideline also endorsed by the American Academy of Family Physicians
via ACP: Metformin as First Oral Tx for T2D (CME/CE)
by
via ACP: Metformin as First Oral Tx for T2D (CME/CE)
by
CardioBrief: A Great Year or Greatest Year Ever?
(MedPage Today) -- Eternal optimist steps in for annual review
via CardioBrief: A Great Year or Greatest Year Ever?
by
via CardioBrief: A Great Year or Greatest Year Ever?
by
Liraglutide Reduces Risk of Heart Events
(MedPage Today) -- Widely-anticipated cardiovascular outcomes trial delivers positive result
via Liraglutide Reduces Risk of Heart Events
by
via Liraglutide Reduces Risk of Heart Events
by
Diabetes Drugs Gain Footing in Cardiology
(MedPage Today) -- 2016 brought CV prevention indication, acceptance
via Diabetes Drugs Gain Footing in Cardiology
by
via Diabetes Drugs Gain Footing in Cardiology
by
Subscribe to:
Posts (Atom)